Emergent BioSolutions Inc.
EBS· NYSE
EBSEmergent BioSolutions Inc.
Source filing unavailable
| Metric | Q3 2012 | Q3 2011 | Q3 2010 |
|---|---|---|---|
| Revenue | $66.59M | $58.76M | $73.99M |
| Net Income | $6.62M | $1.55M | $13.12M |
| EPS Diluted | $0.18 | $0.04 | $0.41 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Emergent BioSolutions Inc. · CIK 1367644 · Engraved from SEC EDGAR
